Literature DB >> 12750737

Safety of rituximab in lymphoma patients with hepatitis B or hepatitis C virus infection.

Masahiro Kami, Tamae Hamaki, Naoko Murashige, Yukiko Kishi, Eiji Kusumi, Koichiro Yuji, Shigesaburo Miyakoshi, Jun-Ichi Ueyama, Shin-Ichi Morinaga, Yoshitomo Mutou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12750737     DOI： 10.1038/sj.thj.6200243

Source DB:  PubMed          Journal:  Hematol J        ISSN： 1466-4860


× No keyword cloud information.
  8 in total

Review 1.  Update on rituximab.

Authors:  R Eisenberg
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

2.  HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questions.

Authors:  Maria Christina Cox; Maria Antonietta Aloe-Spiriti; Elena Cavalieri; Eleonora Alma; Elia Gigante; Paola Begini; Caterina Rebecchini; Gianfranco Delle Fave; Massimo Marignani
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

3.  A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy.

Authors:  Masaaki Hiura; Ryo Onizuka; Ryoichi Narita; Shintaro Abe; Akinari Tabaru; Masaru Harada
Journal:  Clin J Gastroenterol       Date:  2010-09-16

4.  Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.

Authors:  Yin-Hua Wang; Lei Fan; Li Wang; Run Zhang; Ji Xu; Cheng Fang; Jian-Yong Li; Wei Xu
Journal:  Support Care Cancer       Date:  2012-11-15       Impact factor: 3.603

5.  Rituximab-induced acute thrombocytopenia: a case report and review of the literature.

Authors:  Jun Ho Yi; Seok Jin Kim; Hee Kyung Ahn; Su Jin Lee; Myung Hee Chang; Won Seog Kim
Journal:  Med Oncol       Date:  2008-06-10       Impact factor: 3.064

Review 6.  Hepatitis B virus reactivation with rituximab-containing regimen.

Authors:  Yutaka Tsutsumi; Yoshiya Yamamoto; Joji Shimono; Hiroyuki Ohhigashi; Takanori Teshima
Journal:  World J Hepatol       Date:  2013-11-27

7.  'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.

Authors:  Massimo Marignani; Michela di Fonzo; Paola Begini; Elia Gigante; Ilaria Deli; Adriano M Pellicelli; Sara Gallina; Emanuela de Santis; Gianfranco Delle Fave; M Christina Cox
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

8.  Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma.

Authors:  Feng Wang; Rui-hua Xu; Hui-yan Luo; Dong-shen Zhang; Wen-qi Jiang; Hui-qiang Huang; Xiao-fei Sun; Zhong-jun Xia; Zhong-zhen Guan
Journal:  BMC Cancer       Date:  2008-04-23       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.